Suppr超能文献

心脏骤停时药物治疗与生存的关联:高级心血管生命支持药物的作用有限。

Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs.

作者信息

Stiell I G, Wells G A, Hebert P C, Laupacis A, Weitzman B N

机构信息

University of Ottawa Faculty of Medicine, Ontario, Canada.

出版信息

Acad Emerg Med. 1995 Apr;2(4):264-73. doi: 10.1111/j.1553-2712.1995.tb03220.x.

Abstract

OBJECTIVE

To generate hypotheses regarding the association of standard Advanced Cardiac Life Support (ACLS) drugs with human cardiac arrest survival.

METHODS

This observational cohort study was conducted over a two-year period in the wards, intensive care units, and EDs of two tertiary care hospitals. Included werc adult patients who suffered cardiac arrest either inside or outside the hospital and who required epinephrine according to standard ACLS guidelines. Six standard ACLS drugs (given while CPR was in progress) were assessed for association with survival from resuscitation to one hour and to hospital discharge by univariate and multivariate logistic regression analyses.

RESULTS

In the 529 patients studied, initial cardiac rhythm had no impact on the association between drug administration and survival. The time of drug administration (quartile of ACLS period) was associated with resuscitation for atropine (p < 0.05) and lidocaine (p < 0.01). The odds ratios (95% CIs) for successful resuscitation, after multivariate adjustment for potential confounders, were: a respiratory initiating cause, 3.7 (2.1 -6.4); each 5-minute increase in CPR-ACLS interval, 0.5 (0.4-0.7); each 5-minute duration of ACLS. 0.9 (()1.8- 1.0; atropine, 1.2 (1.0-1.3); bretylium. (0.4 (0.1-1.1); calcium 0.8 (0.2-2.4); lidocaine, 0.9 (0.7-1.1); procainamide. 21.0 (5.2-84.0) d sodium bicarbonate 1.2 (1.0-1.6). All other potential confounding variables entered into the model were not significantly associated with resuscitation.

CONCLUSION

Initiating cause of arrest, time to ACLS, and duration of ACLS were important correlates of survival. Other than procainaimide, standard ACLS drugs had relatively little association with survival, but timing of administration may be an important factor. Further research using definitive large randomized controlled trials is warranted to assess the role of drug therapy in improving cardiac arrest survival.

摘要

目的

提出关于标准高级心脏生命支持(ACLS)药物与人类心脏骤停存活之间关联的假设。

方法

这项观察性队列研究在两家三级护理医院的病房、重症监护病房和急诊科进行了两年。纳入的是在医院内或医院外发生心脏骤停且根据标准ACLS指南需要肾上腺素的成年患者。通过单变量和多变量逻辑回归分析,评估了六种标准ACLS药物(在进行心肺复苏时给予)与复苏至一小时存活及出院存活之间的关联。

结果

在研究的529例患者中,初始心律对药物使用与存活之间的关联没有影响。药物给药时间(ACLS期间的四分位数)与阿托品(p < 0.05)和利多卡因(p < 0.01)的复苏相关。在对潜在混杂因素进行多变量调整后,成功复苏的比值比(95%置信区间)为:呼吸起始原因,3.7(2.1 - 6.4);心肺复苏 - ACLS间隔每增加5分钟,0.5(0.4 - 0.7);ACLS每持续5分钟,0.9(0.8 - 1.0);阿托品,1.2(1.0 - 1.3);溴苄铵,0.4(0.1 - 1.1);钙剂,0.8(0.2 - 2.4);利多卡因,0.9(0.7 - 1.1);普鲁卡因酰胺,21.0(5.2 - 84.0);碳酸氢钠,1.2(1.0 - 1.6)。纳入模型的所有其他潜在混杂变量与复苏均无显著关联。

结论

骤停起始原因、至ACLS的时间以及ACLS持续时间是存活的重要相关因素。除普鲁卡因酰胺外,标准ACLS药物与存活的关联相对较小,但给药时间可能是一个重要因素。有必要进行进一步的确定性大型随机对照试验研究,以评估药物治疗在改善心脏骤停存活方面的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验